EU: Evaluation of cannabidiol (CBD) as a novel food suspended

The European Food Safety Authority (EFSA) currently suspending the evaluation of CBD as a novel food, as current scientific documentation does not establish safety in the use of CBD in food, mainly due to lack of documentation, some ambiguities and potential risks associated with CBD consumption.

Chair of the NDA Panel, Prof. Dominique Turck said that during the evaluation, some risks regarding the use of CBD were identified, which must be eliminated by supplementing the scientific documentation before continuing with the work. At the same time, he also points out that this does not mean that they have concluded that CBD is as dangerous as food.

The lack of documentation relates mainly to the effects of CBD on the liver, digestive tract, endocrine and nervous systems, and psychological well-being in humans.

Do you need additional knowledge or help in reviewing the suitability of ingredients and other product properties before entering the market?

With the help of our consulting services, we can fully help you with thorough reviews of the suitability of products for entering the market, as well as foreign markets and opportunities for legal marketing of food supplements.


Cannabidiol novel food evaluations on hold pending new data | EFSA (